We are excited to announce that Nirogy Therapeutics, Inc. has named a new CEO, industry leader, Simon C. Pedder, Ph.D.

Jan 12, 2022

Posted by Nirogy Therapeutics

Publication Finds that Modernization of U.S. Newborn Screening System is Necessary, Calls for Change

Jan 06, 2022

Posted by Orchard Therapeutics

CATO SMS AND PHARM-OLAM MERGE TO CREATE GLOBAL BIOPHARMACEUTICAL SERVICES LEADER

Jan 05, 2022

Posted by Allucent

Novo Nordisk enters research partnership with Empire Discovery Institute

Jan 04, 2022

Posted by Novo Nordisk A/S

Pushing “Fast Forward” on Serialization Requirements: What Manufacturers Need to Do for 2022

Dec 21, 2021

Posted by Converge Consulting LLC

MassBioEdge Preferred Partner In the News: AIS

Dec 21, 2021